Asian Paints' Q2FY24 Financial Performance Review

In this financial performance review, we delve into the results of Asian Paints for the second quarter of fiscal year 2024 and analyze key metrics, including revenue, expenses, net profit, and margin.


ParticularsQ2FY23(Y-o-Y) % changeQ1FY24(Q-o-Q) % changeQ2FY24
Total Income (₹crs.)8,5531.059,379-7.858,643
Expenses (₹crs.)7,480-6.147,305-3.897,021
Net Profit (₹crs.)803.053.421,574-21.731,232
Margin (%)9.394.8716.78-2.5314.25


Asian Paints reported a total income of ₹8,643 crores for Q2FY24, with a slight 1.05% increase compared to the same quarter in the previous fiscal year. However, there was a notable decrease of -7.85% when compared to the preceding quarter, Q1FY24.


Expenses for the company in Q2FY24 amounted to ₹7,021 crores, which reflected a -3.89% decrease compared to the preceding quarter, Q1FY24. On a year-on-year basis, the company managed to reduce expenses by -6.14%.


The net profit of Asian Paints for Q2FY24 was ₹1,232 crores, indicating a significant decline of -21.73% compared to the preceding quarter, Q1FY24. However, on a year-on-year basis, there was a remarkable increase in net profit, with a growth of 53.42%.


Asian Paints' margin in Q2FY24 was 14.25%. This figure indicates a -2.53% decrease compared to the previous quarter when the margin was 16.78%. Year-on-year, the company managed to improve its margins, with a 4.87% increase, showcasing a notable financial achievement.


In conclusion, Asian Paints' financial performance in Q2FY24 reflects a mixed result. While revenue saw a YoY increase and expenses decreased, the decline in net profit and margins from the previous quarter raises some concerns. However, the significant improvement in year-on-year net profit and margin reflects the company's resilience in a challenging economic environment. 


Stay tuned for more detailed updates on Asian Paints' financial performance in the coming quarters.

Top stories

Delta Corp Q1 PAT Declines 68% YoY to Rs 22 crore in FY25

4 mins read . 13 Jul 2024 . 09:30 AM


Zydus Life Gets USFDA Nod for Heart Failure Drug

3 mins read . 13 Jul 2024 . 09:23 AM


RVNL Spurts 10% on Bagging Multiple Orders Worth Rs 390 Cr

4 mins read . 13 Jul 2024 . 09:18 AM

Related Blogs

Share Market


12 mins read . 12 Jul 2024

Ritesh Agarwal: The OYO Founder’s Success Story

  • 0 people read

Share Market


15 mins read . 08 Jul 2024

Best Oil & Gas Stocks in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions